BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• Drug Development

  ProMetic Life Sciences Inc.'s PBI-4050 Cleared To Commence Clinical Trials In Patients With Diabetic Kidney Disease

  November 19, 2014

   · 

  3 min read
• Job Trends

  Shire To Relocate Over 500 Jobs To New Massachusetts Headquarters

  November 19, 2014

   · 

  1 min read
• Genetown

  Radius Health’s Investigational Drug RAD1901 Selected As One Of Informa And Kantar Health’s 2014 Top 10 Most Interesting Oncology Projects To Watch

  November 19, 2014

   · 

  2 min read
• BioMidwest

  Sera Prognostics Recognizes World Prematurity Day 2014

  November 19, 2014

   · 

  3 min read
• Drug Development

  Bio Blast Pharma Receives Orphan Drug Designation From U.S. FDA For Cabaletta For The Treatment Of Spinocerebellar Ataxia Type 3

  November 19, 2014

   · 

  4 min read
• Guided Therapeutics, Inc. Release: Nigerian Clinical Studies Demonstrate Advantages Of LuViva® Advanced Cervical Scan For Screening And Detecting Cervical Pre-Cancer In Africa

  November 19, 2014

   · 

  1 min read
• Pharm Country

  Certara Corporation Updates Its Simcyp Simulator Used To Predict Drug Behavior In Virtual Patient Populations

  November 19, 2014

   · 

  1 min read
• Pharm Country

  CAS Medical Systems, Inc. To Present At The LD MICRO MAIN EVENT: VII Conference On December 2, 2014

  November 19, 2014

   · 

  1 min read
• Drug Development

  BIND Therapeutics Presents Positive Phase 2 Results Highlighting Potential Of BIND-014 As Novel Anti-Cancer Treatment At Q3W Dosing Schedule For Patients With Non-Small Cell Lung Cancer At 26th EORTC-NCI-AACR Annual Symposium

  November 19, 2014

   · 

  11 min read
• Drug Development

  Cempra To Receive Biomedical Advanced Research and Development Authority (BARDA) Funding For 1b And Start-Up Of Phase 2/3 Solithromycin Pediatric Studies

  November 19, 2014

   · 

  6 min read